Sedative effects of low-dose risperidone in GAD patients and risk of drug interactions.
Kopecek
Miloslav
M
Mohr
Pavel
P
Novak
Tomas
T
D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000627:therapeutic use; D001008:Anxiety Disorders / Q000188:drug therapy*; D006970:Disorders of Excessive Somnolence / Q000139:chemically induced; D004305:Dose-Response Relationship, Drug; D004311:Double-Blind Method; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D006801:Humans; D006993:Hypnotics and Sedatives; D010865:Pilot Projects; D011569:Psychiatric Status Rating Scales; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors; D018967:Risperidone / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000627:therapeutic use; D012890:Sleep / Q000187:drug effects; D016896:Treatment Outcome
D014150:Antipsychotic Agents; D006993:Hypnotics and Sedatives; D018967:Risperidone